Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and pharmacology of single
administrations of AVI-6003, a post-exposure prophylaxis candidate treatment for Marburg
virus.